Press release
Digital Insomnia Therapeutics Market Driven by Increased Use of Digital CBT-I Programs and Mobile App Distribution
Digital Insomnia Therapeutics Market
The global Digital Insomnia Therapeutics market is estimated to reach over USD 5.16 billion by the year 2031 exhibiting a CAGR of 5.6% during the forecast period.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1873
Insomnia is a prevalent sleep disorder characterized by difficulty initiating or maintaining sleep. Individuals affected by this condition often experience symptoms such as fatigue, daytime sleepiness, mood disturbances including irritability and depression, and reduced energy levels. Globally, millions are impacted by insomnia, which may result from various underlying factors including chronic pain, hyperthyroidism, menopause, psychological stress, and disruptions to the circadian rhythm. Lifestyle factors, such as excessive intake of caffeine, alcohol, and nicotine, can also contribute to the onset of insomnia.
Diagnosis is typically conducted in specialized sleep laboratories utilizing advanced diagnostic tools. The insomnia therapeutics market is being driven by several factors, including advancements in medical technology, the increasing aging population, greater availability of patented compounds, and a growing pipeline of potential drug candidates currently under clinical investigation. Rising stress levels and increasing awareness of the adverse effects of insufficient sleep on overall health and daily functioning are also contributing to market expansion. As a result, the global insomnia therapeutics market is expected to experience sustained revenue growth over the forecast period.
List of Prominent Players in the Digital Insomnia Therapeutics Market:
• Headspace Inc.
• Big Health
• Calm
• Nox Health
• Pear Therapeutics Inc.
• OPTT Inc.
• SilverCloud
• Curv Health
• Bodymatter, Inc.
• PrimeNap
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Market Dynamics
Drivers:
The demand for digital therapeutics is steadily increasing, driven by their numerous advantages, including the ability to facilitate behavioral modifications, user-friendly interfaces, patient convenience, and improved medication adherence. Advancements in digital technology further support the adoption of these solutions. The widespread use of smartphones and tablets has enabled the growth of healthcare applications that assist in the diagnosis, treatment, and management of various medical conditions. These tools allow for seamless monitoring and recording of vital signs without direct clinical intervention, enabling mobile consultations and enhancing the management of chronic diseases. Additionally, digital therapeutics offer pharmaceutical companies opportunities to extend product life cycles, differentiate offerings under development, and address market gaps left by conventional therapies.
Challenges:
Despite their potential, digital therapeutics face several regulatory and reimbursement challenges. Approval, validation, and reimbursement processes often vary across regulatory bodies, potentially hindering widespread adoption and market penetration. Furthermore, although digital solutions for conditions such as insomnia demonstrate promise, comprehensive clinical research and validation are required to establish their efficacy and safety. Robust clinical trials and evidence-based outcomes are essential for securing approval from regulatory authorities, gaining the trust of healthcare professionals, and ensuring acceptance by stakeholders.
Regional Trends:
North America currently leads the global insomnia therapeutics market in terms of revenue. This dominance is attributed to increasing healthcare expenditure, a rising prevalence of sleep disorders, growing awareness regarding the impact of sleep-related issues, and heightened demand for effective treatment options in the United States and Canada. Additionally, the expanding geriatric population-particularly in the U.S.-and the high incidence of insomnia among older adults are expected to further drive demand. Supportive reimbursement frameworks, a strong clinical development pipeline, and increasing stress levels among the population are also key factors contributing to the region's market growth.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1873
Recent Developments:
• In May 2022, QUVIVIQ, which is intended for the treatment of adult patients with insomnia characterized by symptoms present for at least three months and a significant impact on daytime functioning, was given marketing permission by the European Commission to Idorsia Ltd.
• In January 2022, The United States Food and Drug Administration gave Idorsia permission to market QUVIVIQ 25 and 50 mg for the treatment of individuals with insomnia who have trouble falling asleep or staying asleep.
Segmentation of Digital Insomnia Therapeutics Market-
By Type-
• Sleep Tracking Apps
• Relaxation and Meditation Apps
• Cognitive-Behavioral Therapy for Insomnia (CBT-I)
• Wearable Devices
• Others
By Distribution Channel-
• Hospital Pharmacies
• Retail Pharmacies
• Other Distribution Channel
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/digital-insomnia-therapeutics-market-/1873
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Digital Insomnia Therapeutics Market Driven by Increased Use of Digital CBT-I Programs and Mobile App Distribution here
News-ID: 4067441 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Rare Earth Magnet Market Size, Share and Trends Analysis Report 2025-2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Rare Earth Magnet Market- (By Type (Neodymium-Iron-Boron Magnet (NdFeB), Samarium Cobalt Magnet (SmCo)), Product (Countersunk Magnets, Circular Disc Magnets, Hook & Eyebolt Magnets, Cylindrical Rod Magnets, Circular Ring Magnets, Rectangular, Self-Adhesive, Pot & Clamping Magnets), Application (Automotive Industry, Food & Drink Processing, Aerospace Industry, Renewable Energy, Consumer Electronics, Deep Sea Exploration, Others)), Trends, Industry Competition…
Partially Hydrolyzed Polyacrylamide (PHPA) Market Survey Detailed Analysis and F …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Partially Hydrolyzed Polyacrylamide (PHPA) Market- (By Type (Anionic, Cationic, Non-ionic, Others), By Function (Viscosifying Agent, Shale bore-hole Stabilizer, Excapsulator, Flocculation Agent, Others), By Application (Drilling Fluids, Water Treatment Additive, Soil Stabilization, Paper Manufacturing, Others), By End-Use (Oil & Gas, Waste Water Treatment, Mining, Agriculture, Paper, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According…
Modular Construction Market expected to Witness Huge Revenue Growth to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Modular Construction Market Size, Share & Trends Analysis Report By Type (permanent, relocatable), Module (Four-Sided Modules, Open-Sided Modules, Partially Open Sided Modules, Mixed Modules & Floor Cassettes, Modules Supported By a Primary Structure), Material (steel, wood, concrete), End-user (residential, office, education, retail & commercial, hospitality, healthcare), Region, Market Outlook And Industry Analysis 2034"
The global modular…
Metal Recycling Market Current Scenario with Future Trends Analysis to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Metal Recycling Market- (By Type (Ferrous, Non-Ferrous Metals), By Equipment (Shredders, Shears, Granulating Machines, Briquetting Machines), By End-User (Building and Construction, Packaging, Automotive, Shipbuilding, Electronics Equipment, Electrical Equipment)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Metal Recycling Market Size is valued at 549.4…
More Releases for Insomnia
Emerging Insomnia Market Trends: Revolutionizing Insomnia Therapeutics With Inno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Insomnia Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the insomnia market has been on a constant rise. From $5 billion in 2024, the market is projected to expand to $5.24 billion in 2025, marking a compound annual growth rate…
Insomnia Treatment Market: Embrace Restful Nights and Recharge Your Life with Br …
Insomnia, a common sleep disorder, affects millions of people worldwide. The condition not only disrupts the sleep-wake cycle but also affects overall health and quality of life. With the increasing prevalence of insomnia, the demand for effective treatment options has surged, driving the growth of the insomnia treatment market.
Workflows are getting streamlined due to increased connectivity and quicker internet. This is an era of medical IoT, which goes on to…
Insomnia - Drug Pipeline Landscape, 2023
Insomnia is a sleep disorder that is characterized by difficulty falling asleep or staying asleep. Insomnia can be caused by a variety of factors, including stress, anxiety, depression, medications, and medical conditions. Treatment for insomnia typically includes lifestyle changes, such as avoiding caffeine and establishing a regular sleep schedule, as well as cognitive behavioral therapy and, in some cases, medication.
There are two types of insomnia primary and secondary. Primary insomnia…
Insomnia - Drug Pipeline Landscape, 2022
Insomnia is a progressive, degenerative brain disorder that attacks the brain's nerve cells, or neurons, and causes them to waste away. This disease is characterized by a slow, gradual decline in memory, thinking, and reasoning skills. Alzheimer's is the most common form of dementia, accounting for 60 to 80 percent of all cases. Dementia is a general term for a decline in mental ability severe enough to interfere with daily…
Mattress Sydney – Tips For Preventing Insomnia
Having insomnia? Sleeping on a quality mattress Sydney will improve your situation a lot. Insomnia is a condition in which you have a problem to fall asleep or after falling asleep, you have difficulty keeping that condition. However, it is not a disease, but a symptom.
The concept of a good sleep generally differs from person to person. On average, an adult needs 7-8 hours of night sleep for normal functioning…
Insomnia Market Research Report 2026
Global Insomnia Market: Brief Account
The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases…
